Cervical cancer
A multi-cohort study to evaluate Immune response of cervical cancer patients during radiotherapy.
Who can joinWomen
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial CentreNavi MumbaiDirections ↗
Registry summary (technical)
Systemic and Tumor Immune Response during pelvic (chemo)Radiation and or brachytherapy for cervical cancer (STIRR Cervix Study) - STIRR
Sponsor: Tata Memorial Hospital
CTRI/2025/04/083811 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 17 Nov 2025 · read by us 5 Nov 2026